Thanks to all who attended the CU Anschutz Innovation Forum
CU Innovations, Startup Toolbox and Academia Industry Alliance (AIA) hosted a 3-day event on June 10-12th that highlighted the diversity of innovation at the University of Colorado Anschutz Medical Campus.
Engaging presentations and panel discussions demystified the innovation journey. Key sessions covered company formation, building inclusive teams and career opportunities. CU researchers, start-ups and industry partners participated and networked at this successful event!
Congratulations to the winners of the Venture Showcase: NowVitals, pitched by Robin Deterding, MD, and Vināśa Oncology, pitched by Sujatha Venkataraman, PhD!
(1/19)
(2/19)
(3/19)
(4/19)
(5/19)
(6/19)
(7/19)
(8/19)
(9/19)
(10/19)
(11/19)
(12/19)
(13/19)
(14/19)
(15/19)
(16/19)
(17/19)
(18/19)
(19/19)
Agenda
Building upon the success of last year's Stories of Women-Led Innovation Event, this forum continued highlighting the achievements and challenges faced by our women innovators and demystifying the innovation pathway through presentations and panel discussions. Sessions covered intellectual property protection, building inclusive teams and addressing bias in the context of academic innovation.
Attendees were excited to hear from our keynote speaker, Gitanjali Rao, aspiring scientist, inventor and author!
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
This event aimed to educate and inspire entrepreneurs at all stages. Featuring panels on company formation, funding biomedical discoveries and creating strategic alliances, each session included interactive elements and the chance to network with potential partners from the Anschutz campus and beyond.
Attendees got to know Jodie Morrison, CEO of Q32 Bio, and Kimberly Muller, Executive Director of CU Innovations, through their Fireside Chat Keynote.
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Congratulations to the judge vote winner, NowVitals pitched by Robin Deterding, MD, and the audience vote winner, Vināśa Oncology pitched by Sujatha Venkataraman, PhD!
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
With sessions featuring scientific talks, career panels, and a 2-hour networking lunch, RMBTS offered a prime platform to highlight scientific advancements and career opportunities, and foster collaboration within Colorado's scientific community.
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Elyse Blazevich MS, BA
(Moderator)
President & CEO, Colorado BioScience Association
Elyse Blazevich leads CBSA’s work to create co-opportunity for Colorado’s life sciences community. Together with the CBSA Board of Directors, team, partners, sponsors, and members, she strategically advances CBSA’s efforts to build a collaborative environment for health innovation.
Elyse brings deep knowledge of life sciences company needs, CBSA as an organization, and Colorado’s business community to offer continuity, connections, and a clear vision for the future of CBSA and the ecosystem it represents. Before joining CBSA, she co-founded Securisyn Medical and led the organization as COO and CFO, transitioning the company from a founder-led startup to a professionally led, commercial-stage medical device company. She remains a member of the Securisyn Medical Board of Directors.
She understands what it takes to lead a Colorado life sciences company from concept to commercialization. Together with the Securisyn Medical team, she:
- Secured $15 million in capital, including $4 million in non-dilutive government funding.
- >Developed and expanded a product pipeline from one to five devices.
- Built an intellectual property portfolio with 12 patents.
- Completed two Phase I and subsequent Phase II SBIR contracts.
- Achieved 510(k) market clearance for a Class II medical device.
- Championed state programs run by the Office of Economic Development and International Trade. to support Colorado’s advanced industries. She advocated for Colorado’s Advanced Industries Accelerator Grant Program after receiving a $250,000 Early-Stage Capital & Retention Grant and the Advanced Industries Investment Tax Credit, which she used to raise follow-on capital for Securisyn Medical.
Previously, Elyse led investor relations for the South Metro Denver Chamber of Commerce. She has also served as a board member and leader for Project C.U.R.E. and the Blue Bench in addition to her board leadership role with CBSA.
Born and raised in Colorado, Elyse holds a B.A. in biology from Colorado College and earned her M.S. in organizational leadership from CSU Global. She is also a graduate of the Colorado BioScience Institute’s Executive Leadership program.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
Event Sponsors
Thank you to our sponsors for making this forum possible! We are greatly appreciative of your continued support.
PLATINUM SPONSORS:
SPONSORS:
